Vatalanib hydrochloride
Based on 15 publication(s) in Google Scholar
Vatalanib (PTK787; ZK-222584; CGP-797870) hydrochloride is a BBB-permeable VEGFR2/KDR inhibitor with an IC50 of 37 nM.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 212141-52-1
- Formule: C20H16Cl2N4
- Masse moléculaire:383.27
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Vatalanib hydrochloride
More- Bioact Mater. 2022 Jan 2:15:131-144. [Abstract]
- Sci Transl Med. 2018 Jul 18;10(450):eaaq1093. [Abstract]
- J Pharm Anal. 2024 Jan;14(1):100-114. [Abstract]
- Br J Pharmacol. 2019 Sep;176(17):3143-3160. [Abstract]
- JCI Insight. 2024 May 22;9(10):e166402. [Abstract]
- Int J Mol Sci. 2024 Nov 15;25(22):12277. [Abstract]
- Oncol Rep. 2016 Mar;35(3):1297-308. [Abstract]
- J Microbiol Biotechnol. 2015 Aug;25(8):1227-33. [Abstract]
- Mutat Res. 2025 Jul-Dec:831:111916. [Abstract]
- Drug Metab Pharmacokinet. 2017 Jun;32(3):179-188. [Abstract]
- Ulm University. 2023 Mar 21.
- Oxid Med Cell Longev. 2022 Jul 18:2022:2232365. [Abstract]
- Evid Based Complement Alternat Med. 2021 Apr 26:2021:5543259. [Abstract]
- Patent. US20170349880A1.
- Kitasato University. 2017.
Voir tous les produits spécifiques à Isoform VEGFR
More
Activité biologique
Chemical Information
-
CAS No. 212141-52-1
-
Masse moléculaire 383.27
-
Formule C20H16Cl2N4
-
SMILES
ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C4=C2C=CC=C4)C=C1.[H]Cl
-
Synonyms
PTK787 hydrochloride; ZK-222584 hydrochloride; CGP-797870 hydrochloride
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (15)
-
Journal Impact Factor
-
Most Recent
-
Bioact Mater
2022 Jan 2:15:131-144. PMID: 35386336 -
Sci Transl Med
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells. [Abstract]2018 Jul 18;10(450):eaaq1093. PMID: 30021885 -
J Pharm Anal
Distinct molecular targets of ProEGCG from EGCG and superior inhibition of angiogenesis signaling pathways for treatment of endometriosis. [Abstract]2024 Jan;14(1):100-114. PMID: 38352946 -
Br J Pharmacol
Tanshinol borneol ester, a novel synthetic small molecule angiogenesis stimulator inspired by botanical formulations for angina pectoris. [Abstract]2019 Sep;176(17):3143-3160. PMID: 31116880 -
JCI Insight
Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis. [Abstract]2024 May 22;9(10):e166402. PMID: 38775153 -
Int J Mol Sci
Targeting Myeloid Cells in Head and Neck Squamous Cell Carcinoma: A Kinase Inhibitor Library Screening Approach. [Abstract]2024 Nov 15;25(22):12277. PMID: 39596341 -
Oncol Rep
Local recurrence of small cell lung cancer following radiofrequency ablation is induced by HIF-1α expression in the transition zone. [Abstract]2016 Mar;35(3):1297-308. PMID: 26750332 -
J Microbiol Biotechnol
Soluble Expression and Purification of the Catalytic Domain of Human Vascular Endothelial Growth Factor Receptor 2 in Escherichia coli. [Abstract]2015 Aug;25(8):1227-33. PMID: 25907066 -
Mutat Res
Deciphering the molecular mechanism of YY1/HIF1A modulating ovarian cancer angiogenesis based on single-cell transcriptomics technology. [Abstract]2025 Jul-Dec:831:111916. PMID: 41072350 -
Drug Metab Pharmacokinet
Precise prediction of activators for the human constitutive androstane receptor using structure-based three-dimensional quantitative structure-activity relationship methods. [Abstract]2017 Jun;32(3):179-188. PMID: 28412023 -
-
Oxid Med Cell Longev
Tetramethylpyrazine Protects Endothelial Injury and Antithrombosis via Antioxidant and Antiapoptosis in HUVECs and Zebrafish. [Abstract]2022 Jul 18:2022:2232365. PMID: 35898617 -
Evid Based Complement Alternat Med
Inhibitory Effects of Euphorbia ebracteolata Hayata Extract ECB on Melanoma-Induced Hyperplasia of Blood Vessels in Zebrafish Embryos. [Abstract]2021 Apr 26:2021:5543259. PMID: 33995546 -
-
Pureté et documentation
Références
[1]. Wood JM, et al. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 2000;60(8):2178-2189. [Content Brief]
[2]. Wan J, et al. Local recurrence of small cell lung cancer following radiofrequency ablation is induced by HIF-1α expression in the transition zone. Oncol Rep. 2016;35(3):1297-1308. [Content Brief]
[3]. Murakami M, et al. Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-α/5-fluorouracil therapy for hepatocellular carcinoma cells. Ann Surg Oncol. 2011;18(2):589-596. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Vatalanib hydrochloride Related Classifications
HY-12018A Related Classifications
Powered by Bioz